New Delhi: Various types of research are still going on around the world to defeat the corona virus. In the last few days, there has been a lot of discussion about the mixed dose of corona virus vaccine. So far, no harmful effects have been reported in those who have taken the mixture dose of the vaccine. Meanwhile, the Pune-based National Institute of Virology, in a study released on vaccine mixtures, said that a single dose of a mixture of Covaxin and Covishield in people increases immunity more than two doses of a vaccine. The institute also took the initiative of giving the vaccine cocktail dosage as has been done in many countries before.
ICMR National Institute of Virology Pune studied the vaccine cocktail on 18 people. For the time being, this testing is yet to be reviewed. Individuals in the study were compared with people who were given either Covishield or Covaxin. Let us know in detail what was the effect of the mixture of vaccines and in which countries the cocktail of vaccines is being given.
These countries have allowed mixing doses of different vaccines.
Canada – Canada has allowed a mix of Covid 19 vaccines to meet the supply shortage of the corona vaccine and to address the growing health concerns in the country. By doing this it is expected that there will be a reduction in taking two doses of the vaccine.
Thailand allowed the addition of the AstraZeneca Kovid-19 vaccine as a second dose. The AstraZeneca vaccine was given to people who had taken Sinovac in the first dose. This move by Thailand was the first publicly mix and match of a Chinese vaccine. The country’s Health Minister Anutin Charnvirakul said about this that this is to make the protection against delta infection more strong.
Vietnam announced on July 13 that it would give the mRNA vaccine jointly developed by Pfizer and BioNTech as a second dose to people who had received the AstraZeneca vaccine in the first dose.
After banning the use of the AstraZeneca vaccine, the Italian government passed orders to vaccinate people under the age of 60 with the Pfizer or Moderna vaccine. These vaccines were to be given to people who had received their first dose of AstraZeneca.
In June, Bhutan’s prime minister said he had no problem with allowing a mix of the Covid-19 vaccine to make up for the short supply of vaccines. He told that more than 90 percent of the country’s population was given the AstraZeneca vaccine as the first dose of the vaccine and now the 12-week gap between the second dose is about to end this month.
On 14 April, Finland’s Institute of Health and Wellness announced that anyone under the age of 65 could receive their first dose of AstraZeneca vaccine and then an alternate shot for their second dose.
In April, France’s top health advisory council suggested that individuals under the age of 55 who had previously been given AstraZeneca should be given a second dose of the so-called messenger RNA vaccination.
Norway also agreed on a cocktail of vaccines, saying on April 23 that patients who received a single dose of the AstraZeneca vaccine would receive a second dose of the mRNA vaccine.
On May 19, Spanish Health Minister Carolina Darías said that people under the age of 60 who had previously received the AstraZeneca vaccine could receive a second dose of AstraZeneca or Pfizer vaccine.
In January, the United Kingdom announced that in exceptionally unusual circumstances, such as when the initial vaccine went out of stock, people would be offered a different vaccine for a second dose.